Literature DB >> 12655561

A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T.

Paula M Hempen1, Harsha Kurpad, Eric S Calhoun, Susan Abraham, Scott E Kern.   

Abstract

To determine sequence variations of the BUB1 and BUB1B genes in pancreatic cancer, the entire coding regions of the BUB1 and BUB1B genes were sequenced in pancreatic cancer cell lines and xenografts. Although only polymorphic alterations were found in the BUB1B gene, the aneuploid pancreatic cell line Hs766T had two novel missense variants (p.[Y259C;H265N]) in the BUB1 gene. These mutations were on the same allele, accompanied by a wild-type BUB1 allele. This change was not found in other samples, the literature, or 110 additional chromosomes from a reference population. Compared to two cell lines having microsatellite instability (MIN), the TP53 wild-type pancreatic cell line Hs766T had a defective mitotic spindle checkpoint, indicative of a cell line with chromosomal instability (CIN). Evidence that this checkpoint pathway can be abrogated by mutations in the BUB1 gene (Cahill et al., 1998) supports the suggestion the missense mutations of the BUB1 gene in the Hs766T cell line may contribute to its observed mitotic checkpoint defect. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655561     DOI: 10.1002/humu.9120

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

Review 1.  Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

Authors:  Juan-Manuel Schvartzman; Rocio Sotillo; Robert Benezra
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

2.  Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.

Authors:  Zhiguo Sun; Bingyi Xiao; Hem Chandra Jha; Jie Lu; Shuvomoy Banerjee; Erle S Robertson
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

3.  RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.

Authors:  Yan Hu; Ting Wang; Gary D Stormo; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-01       Impact factor: 11.205

Review 4.  BUB1 and BUBR1: multifaceted kinases of the cell cycle.

Authors:  Victor M Bolanos-Garcia; Tom L Blundell
Journal:  Trends Biochem Sci       Date:  2010-10-15       Impact factor: 13.807

5.  Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation.

Authors:  Robin M Ricke; Karthik B Jeganathan; Jan M van Deursen
Journal:  J Cell Biol       Date:  2011-06-06       Impact factor: 10.539

6.  Induction of chromosome instability and stomach cancer by altering the expression pattern of mitotic checkpoint genes in mice exposed to areca-nut.

Authors:  Sillarine Kurkalang; Atanu Banerjee; Nitin Ghoshal; Hughbert Dkhar; Anupam Chatterjee
Journal:  BMC Cancer       Date:  2013-06-28       Impact factor: 4.430

7.  Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach.

Authors:  Yanfen Ma; Jian Hu; Ning Zhang; Xinran Dong; Ying Li; Bo Yang; Weidong Tian; Xiaoqin Wang
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

8.  Bub1 regulates chromosome segregation in a kinetochore-independent manner.

Authors:  Christiane Klebig; Dirk Korinth; Patrick Meraldi
Journal:  J Cell Biol       Date:  2009-06-01       Impact factor: 10.539

9.  Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis.

Authors:  Zhanwei Wang; Dionyssios Katsaros; Yi Shen; Yuanyuan Fu; Emilie Marion Canuto; Chiara Benedetto; Lingeng Lu; Wen-Ming Chu; Harvey A Risch; Herbert Yu
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

10.  Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profile.

Authors:  Jin Long; Zhe Liu; Xingda Wu; Yuanhong Xu; Chunlin Ge
Journal:  Mol Med Rep       Date:  2016-03-18       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.